The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL

Authors: Assouline, Sarit ^*, Li, Shen ^*, Gisselbrecht, Christian, Fogarty, Patrick, Hay, Annette, van den Neste, Eric, Shepherd, Lois E., Schmitz, Norbert, Baetz, Tara, Keating, Armand, Robinson, Sue, Seftel, Matthew, Stelitano, Caterina, Djurfeldt, Marina S., Meyer, Ralph, Chen, Bingshu E., Crump, Michael

Source: In Blood Advances 12 May 2020 4(9):2011-2017

Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12

Authors: Kuruvilla, John ^*, MacDonald, David A., Kouroukis, C. Tom, Cheung, Matthew, Olney, Harold J., Turner, A. Robert, Anglin, Peter, Seftel, Matthew, Ismail, Walid Sabry, Luminari, Stefano, Couban, Stephen, Baetz, Tara, Meyer, Ralph M., Hay, Annette E., Shepherd, Lois, Djurfeldt, Marina S., Alamoudi, Sameer, Chen, Bingshu E., Crump, Michael

Source: In Blood 6 August 2015 126(6):733-738

Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12

Authors: Baetz, Tara, Chen, Bingshu E., Couban, Stephen, Tom Kouroukis, C., Buckstein, Rena, Kuruvilla, John, Howson-Jan, Kang, Szwajcer, David, Federico, Massimo, Meyer, Ralph M., Djurfeldt, Marina S., Hay, Annette E., Shepherd, Lois, Crump, Michael

Source: Leukemia & lymphoma. 58(1):64-69

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100049433966.0x000001&indx=1&recIds=ETOCvdc_100049433966.0x000001

Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.

Authors: Gupta, Arjun, Hay, Annette E, Crump, Michael, Djurfeldt, Marina S, Zhu, Liting, Cheung, Matthew C, Shepherd, Lois E, Chen, Bingshu E, Booth, Christopher M

Source: Oncologist; Sep2023, Vol. 28 Issue 9, p799-803, 5p, 2 Charts

Subject Terms: STEM cell transplantation, THERAPEUTIC use of antineoplastic agents, DISEASE progression, TIME, DEXAMETHASONE, CANCER chemotherapy, GEMCITABINE, DISEASE relapse, TREATMENT effectiveness, CISPLATIN, DESCRIPTIVE statistics, DECISION making, PATIENT-professional relations, LYMPHOMAS, CYTARABINE, SECONDARY analysis, OUTPATIENT services in hospitals

Use of Severity of Illness to Evaluate Quality of Care

Authors: MACKENZIE, THOMAS A., GREENAWAY-COATES, ALISON, DJURFELDT, MARINA S., HOPMAN, WILMA M.

Source: International Journal for Quality in Health Care, 1996 Apr 01. 8(2), 125-130.

Access URL: https://www.jstor.org/stable/45125143

Development and Testing of a Lymphoma Clinical Trials Specific Frailty Index: A Secondary Analysis of the LY.12 Clinical Trial

Authors: Vijenthira, Abi, Li, Xinzhi, Crump, Michael, Hay, Annette E., Shepherd, Lois E., Meyer, Ralph, Djurfeldt, Marina S., Chen, Bingshu E., Prica, Anca

Source: In Blood 23 November 2021 138 Supplement 1:4076-4076

Event-Free Survival As a Surrogate for Overall Survival in Relapsed DLBCL after Autologous Transplant: A Subgroup Analysis of LY.12 and Coral

Authors: Assouline, Sarit, Li, Shen ^*, Gisselbrecht, Christian, Fogarty, Patrick ^*, Hay, Annette E., Van Den Neste, Eric ^*, Shepherd, Lois E., Schmitz, Norbert ^*, Baetz, Tara ^*, Keating, Armand, Robinson, Sue ^*, Seftel, Matthew D., Stelitano, Caterina ^*, Djurfeldt, Marina S. ^*, Meyer, Ralph, Chen, Bingshu E. ^*, Crump, Michael

Source: In Blood 13 November 2019 134 Supplement 1:768-768

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Authors: Prica, Anca, Hay, Annette E, Crump, Michael, Mittman, Nicole ^*, Shepherd, Lois E., Meyer, Ralph, Imrie, Kevin, Risebrough, Nancy A. ^*, Djurfeldt, Marina S ^*, Chen, Bingshu E. ^*, Cheung, Matthew

Source: In Blood 8 December 2017 130 Supplement 1:4673-4673

Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial

Authors: Rodriguez-Romo, Laura N ^*, Meyer, Ralph, Pater, Joseph L ^*, Sussman, Jonathan ^*, Zhang, Siwei ^*, Hongbo, Lui ^*, Winter, Jane N., Vuong, Te ^*, Blahey, Walter ^*, Mulroy, Liam ^*, Shepherd, Lois E., Djurfeldt, Marina S ^*, Chen, Bingshu E. ^*, Hay, Annette E

Source: In Blood 8 December 2017 130 Supplement 1:4081-4081

Potential Utility of Event-Free Survival (EFS) As Surrogate Endpoint for Overall Survival (OS) in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) after Autologous Stem Cell Transplantation (ASCT): A Subgroup Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Randomized Phase III Trial

Authors: Li, Shen ^*, Hay, Annette E, Crump, Michael, Anglin, Peter, Baetz, Tara ^*, Meyer, Ralph, Keating, Armand, Robinson, Sue ^*, Seftel, Matthew, Stelitano, Caterina ^*, Djurfeldt, Marina S ^*, Shepherd, Lois E., Chen, Bingshu E. ^*, Assouline, Sarit

Source: In Blood 8 December 2017 130 Supplement 1:2015-2015

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Addition of Rituximab to Salvage Chemotherapy in Aggressive CD20+ Lymphoma Prior to Autologous Stem Cell Transplant (ASCT): A Cohort Comparison from the NCIC CTG Study LY.12

Authors: Baetz, Tara ^*, Chen, Bingshu E ^*, Couban, Stephen, Kouroukis, C. Tom, Buckstein, Rena, Kuruvilla, John, Howson-Jan, Kang ^*, Szwajcer, David, Federico, Massimo, Meyer, Ralph M., Turner, Robert ^*, Djurfeldt, Marina S ^*, Hay, Annette E, Shepherd, Lois, Crump, Michael

Source: In Blood 6 December 2014 124(21):1712-1712

This result is not displayed to guests.
Login for full access.

Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6

Authors: Meyer, Ralph M., Gospodarowicz, Mary ^*, Connors, Joseph M., Pearcey, Robert G ^*, Wells, Woodrow A ^*, Winter, Jane N., Horning, Sandra J., Dar, A. Rashid ^*, Shustik, Chaim, Stewart, Douglas A., Crump, Michael, Djurfeldt, Marina S ^*, Chen, Bingshu E ^*, Shepherd, Lois E

Source: In Blood 18 November 2011 118(21):590-590

Relapse Patterns and Subsequent Outcomes of Patients Treated on the NCIC CTG HD.6 (ECOG JHD06) Randomized Trial Evaluating ABVD Alone in Patients with Limited Stage Hodgkin Lymphoma (HL).

Authors: Macdonald, David A., Gospodarowicz, Mary K. ^*, Wells, Woodrow A. ^*, Pearcey, Robert G. ^*, Connors, Joseph M., Winter, Jane N., Horning, Sandra J., Djurfeldt, Marina S. ^*, Ding, Keyue ^*, Shepherd, Lois E., Meyer, Ralph M.

Source: In Blood 16 November 2005 106(11):817-817